11/28
04:59 pm
telo
Form PRER14A Telomir Pharmaceuticals,
Medium
Report
Form PRER14A Telomir Pharmaceuticals,
11/24
04:02 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Nov 24
Medium
Report
Form 8-K Telomir Pharmaceuticals, For: Nov 24
11/20
05:15 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Nov 14
Medium
Report
Form 8-K Telomir Pharmaceuticals, For: Nov 14
11/20
04:17 pm
telo
Form PREM14A Telomir Pharmaceuticals, For: Nov 20
High
Report
Form PREM14A Telomir Pharmaceuticals, For: Nov 20
11/20
04:02 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Nov 20
Medium
Report
Form 8-K Telomir Pharmaceuticals, For: Nov 20
11/12
07:01 am
telo
Form 8-K Telomir Pharmaceuticals, For: Nov 12
Medium
Report
Form 8-K Telomir Pharmaceuticals, For: Nov 12
11/10
04:02 pm
telo
Form 10-Q Telomir Pharmaceuticals, For: Sep 30
Low
Report
Form 10-Q Telomir Pharmaceuticals, For: Sep 30
10/22
04:02 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Oct 22
Medium
Report
Form 8-K Telomir Pharmaceuticals, For: Oct 22
10/20
06:48 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Oct 17
High
Report
Form 8-K Telomir Pharmaceuticals, For: Oct 17
10/14
07:31 am
telo
Form 8-K Telomir Pharmaceuticals, For: Oct 14
Medium
Report
Form 8-K Telomir Pharmaceuticals, For: Oct 14
10/8
04:02 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Oct 08
High
Report
Form 8-K Telomir Pharmaceuticals, For: Oct 08
10/6
04:02 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Oct 06
High
Report
Form 8-K Telomir Pharmaceuticals, For: Oct 06
10/3
08:00 pm
telo
Form 3 Telomir Pharmaceuticals, For: Sep 29 Filed by: MIRA PHARMACEUTICALS, INC.
Low
Report
Form 3 Telomir Pharmaceuticals, For: Sep 29 Filed by: MIRA PHARMACEUTICALS, INC.
9/18
06:48 pm
telo
Form SCHEDULE 13G Telomir Pharmaceuticals, Filed by: DEJORIA JOHN PAUL
Medium
Report
Form SCHEDULE 13G Telomir Pharmaceuticals, Filed by: DEJORIA JOHN PAUL
9/18
07:31 am
telo
Form 8-K Telomir Pharmaceuticals, For: Sep 18
Low
Report
Form 8-K Telomir Pharmaceuticals, For: Sep 18
9/9
07:31 am
telo
Form 8-K Telomir Pharmaceuticals, For: Sep 09
High
Report
Form 8-K Telomir Pharmaceuticals, For: Sep 09